Home example 2 - Pharmamarketeer

wet- en regelgeving

Biogen retracts EMA application for Alzheimer’s drug Aduhelm

The application was pulled after the CHMP said the data provided was not enough to support a marketing authorisation

PMLiVE

3 x gelezen

marketing

Is Speed and Not AI Technology the Real Enemy in Marketing?

Is Speed and Not AI Technology the Real Enemy in Marketing? More than 25 years ago, I managed one of the most innovative types of companies on the planet – a website development agency (yes, really). Remember, this was...

Content Marketing Institute

3 x gelezen

overig

UK GPs are undervalued; with 40% looking to quit profession, study finds

Falling numbers of General Practitioners (GPs) in the UK are due to “concerns regarding professional risk in delivering care in an increasingly complex health environment”, and a feeling general practice-based primary...

Pharmafile

3 x gelezen

technologie

Miniaturized pipe organ could help improve quality of medical images

A miniaturized version of a musical instrument that could be used to improve the quality of medical images has been manufactured by researchers at the University of Strathclyde.

News-Medical.Net

3 x gelezen

farma-industrie wet- en regelgeving

Abbvies chronic lymphocytic leukaemia drug Venclytxo scores greenlight from NICE

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s Venclyxto (venetoclax) in combination with Genentech’s Rituxan (rituximab) on the NHS as a treatment...

InPharm.com

3 x gelezen

wet- en regelgeving

Biosimilar Cancer Treatment Ontruzant Gets FDA Approval

Prior to treatment, HER2 testing using FDA-approved tests should be performed.

Monthly Prescribing Reference (MPR): Drug News

3 x gelezen

wet- en regelgeving

FDA generics approvals up 90% compared to 2014

Continuing to build on its successes in toppling previous benchmarks, it has emerged that the FDA’s total number of generic drug approvals this year is 90% higher compared to the fiscal year of 2014. Throughout the...

InPharm.com

3 x gelezen

farma-industrie

Johnson & Johnson scraps Alzheimer’s trials on safety concerns

Johnson and Johnson said it would stop mid-stage trials testing its experimental Alzheimer’s drug after observing safety issues, the latest drugmaker to abandon developing treatments for the memory-robbing disease.

Reuters

3 x gelezen

marketing technologie

De 5 AI-trends om naar uit te kijken in 2019

De interesse in artificial intelligence (AI) stijgt naar een hoogtepunt. In 2018 was er al een aanzienlijke groei van bedrijfsapplicaties op basis van AI en machine learning (ML). Deze trend zet zich...

Frankwatching.nl

3 x gelezen

farma-industrie

Pharmacy in future: Transformational change is essential in all practice settings

Medications improve health and saves lives, but they are not risk-free. The modern pharmacist is largely responsible for helping patients navigate an increasingly complex and costly health care system, particularly with...

News-Medical.Net

3 x gelezen

Latest articles

Biogen retracts EMA application for Alzheimer’s drug Aduhelm

Is Speed and Not AI Technology the Real Enemy in Marketing?

UK GPs are undervalued; with 40% looking to quit profession, study finds

Miniaturized pipe organ could help improve quality of medical images

Abbvies chronic lymphocytic leukaemia drug Venclytxo scores greenlight from NICE

Biosimilar Cancer Treatment Ontruzant Gets FDA Approval

FDA generics approvals up 90% compared to 2014

Johnson & Johnson scraps Alzheimer’s trials on safety concerns

De 5 AI-trends om naar uit te kijken in 2019

Pharmacy in future: Transformational change is essential in all practice settings

Wekelijkse highlights per e-mail

Algemene informatie